Article
Methylglyoxal Drives a Distinct, Nonclassical Macrophage Activation Status.
Thrombosis and haemostasis - 1 Nov 2021
Tsokanos Foivos-Filippos, Muley Carolin, Khani Sajjad, Hass Daniela, Fleming Thomas, Wolff Gretchen, Bartelt Alexander, Nawroth Peter, Herzig Stephan
Abstract excerpt
Metabolic complications in diabetic patients are driven by a combination of increased levels of nutrients and the presence of a proinflammatory environment. Methylglyoxal (MG) is a toxic byproduct of catabolism and has been strongly associated with the development of such complications. Macrophages are key mediators of inflammatory processes and their contribution to the development of metabolic complications has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
